Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [15]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66281-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- YY1 antibody
- Antibody type
- Monoclonal
- Description
- YY1 antibody (Cat. #66281-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse, rat, monkey and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2E11C5
- Vial size
- 150ul
Submitted references YY1-mediated reticulocalbin-2 upregulation promotes the hepatocellular carcinoma progression via activating MYC signaling.
Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b.
Acinetobacter baumannii up-regulates LncRNA-GAS5 and promotes the degradation of STX17 by blocking the activation of YY1.
Cypermethrin triggers YY1-mediated testosterone biosynthesis suppression.
Transcription factor YY1 enhances the stemness of lung cancer cells by stabilizing hypoxia factor HIF-1α under a hypoxic microenvironment.
Yin Yang 1 is critical for mid-hindbrain neuroepithelium development and involved in cerebellar agenesis.
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.
FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.
Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription.
The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p.
hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.
miR-29b contributes to multiple types of muscle atrophy.
MicroRNA-29a promotes smooth muscle cell differentiation from stem cells by targeting YY1.
Mei C, Jiang X, Gu Y, Wu X, Ma W, Chen X, Wang G, Yao Y, Liu Y, Zhang Z, Yuan Y
American journal of cancer research 2021;11(5):2238-2251
American journal of cancer research 2021;11(5):2238-2251
Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b.
Li J, Yang T, Sha Z, Tang H, Hua X, Wang L, Wang Z, Gao Z, Sluijter JPG, Rowe GC, Das S, Yang L, Xiao J
Molecular therapy. Nucleic acids 2021 Mar 5;23:743-756
Molecular therapy. Nucleic acids 2021 Mar 5;23:743-756
Acinetobacter baumannii up-regulates LncRNA-GAS5 and promotes the degradation of STX17 by blocking the activation of YY1.
An Z, Ding W
Virulence 2021 Dec;12(1):1965-1979
Virulence 2021 Dec;12(1):1965-1979
Cypermethrin triggers YY1-mediated testosterone biosynthesis suppression.
Liu C, Qu J, Wu M, Huang X, Li L
Ecotoxicology and environmental safety 2021 Dec 1;225:112792
Ecotoxicology and environmental safety 2021 Dec 1;225:112792
Transcription factor YY1 enhances the stemness of lung cancer cells by stabilizing hypoxia factor HIF-1α under a hypoxic microenvironment.
Huang X, Zhou W, Zhang Y
Environmental toxicology 2020 Sep 3;
Environmental toxicology 2020 Sep 3;
Yin Yang 1 is critical for mid-hindbrain neuroepithelium development and involved in cerebellar agenesis.
Dong X, Kwan KM
Molecular brain 2020 Jul 23;13(1):104
Molecular brain 2020 Jul 23;13(1):104
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.
Cataldo A, Romero-Cordoba S, Plantamura I, Cosentino G, Hidalgo-Miranda A, Tagliabue E, Iorio MV
Cancers 2020 Aug 12;12(8)
Cancers 2020 Aug 12;12(8)
FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.
Yang W, Feng B, Meng Y, Wang J, Geng B, Cui Q, Zhang H, Yang Y, Yang J
Journal of cellular and molecular medicine 2019 May;23(5):3464-3475
Journal of cellular and molecular medicine 2019 May;23(5):3464-3475
Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription.
Xiao R, Chen JY, Liang Z, Luo D, Chen G, Lu ZJ, Chen Y, Zhou B, Li H, Du X, Yang Y, San M, Wei X, Liu W, Lécuyer E, Graveley BR, Yeo GW, Burge CB, Zhang MQ, Zhou Y, Fu XD
Cell 2019 Jun 27;178(1):107-121.e18
Cell 2019 Jun 27;178(1):107-121.e18
The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
Tang W, Zhou W, Xiang L, Wu X, Zhang P, Wang J, Liu G, Zhang W, Peng Y, Huang X, Cai J, Bai Y, Bai L, Zhu W, Gu H, Xiong J, Ye C, Li A, Liu S, Wang J
Nature communications 2019 Feb 8;10(1):663
Nature communications 2019 Feb 8;10(1):663
CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p.
Rong D, Lu C, Zhang B, Fu K, Zhao S, Tang W, Cao H
Molecular cancer 2019 Feb 18;18(1):25
Molecular cancer 2019 Feb 18;18(1):25
hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T, An Z, Zhang C, Wang Z, Wang X, Liu Y, Du E, Liu R, Zhang Z, Xu Y
The Prostate 2019 Aug;79(11):1199-1210
The Prostate 2019 Aug;79(11):1199-1210
CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.
Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T, Sun H, Pan Y, He B, Wang S
Cell death & disease 2018 Apr 1;9(4):417
Cell death & disease 2018 Apr 1;9(4):417
miR-29b contributes to multiple types of muscle atrophy.
Li J, Chan MC, Yu Y, Bei Y, Chen P, Zhou Q, Cheng L, Chen L, Ziegler O, Rowe GC, Das S, Xiao J
Nature communications 2017 May 25;8:15201
Nature communications 2017 May 25;8:15201
MicroRNA-29a promotes smooth muscle cell differentiation from stem cells by targeting YY1.
Jin M, Wu Y, Wang Y, Yu D, Yang M, Yang F, Feng C, Chen T
Stem cell research 2016 Sep;17(2):277-284
Stem cell research 2016 Sep;17(2):277-284
No comments: Submit comment
No validations: Submit validation data